Allergan/Gedeon uterine fibroids therapy headed for NDA

Allergan plc (NYSE:AGN) and Gedeon Richter Ltd. (Budapest:RICHTER) said ulipristal acetate (PGL4001) met all co-primary and secondary endpoints in VENUS II, the second of two

Read the full 259 word article

User Sign In